Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sixth Wave Innovations Inc SIXWF

Sixth Wave Innovations Inc. is a Canada-based nanotechnology company with patented technologies. The Company is focused on the extraction and detection of target substances at the molecular level using specialized molecularly imprinted polymers (MIPs). The Company’s product brands include AMIPs, IXOS and Affinity. The IXOS is a line of extraction polymers formulated for deployment in the gold mining industry. The Affinity system is using its MIPs, which are designed to capture and extract cannabinoids from filtered crude extracts without the use of traditional winterization and distillation. The Company’s patent portfolio covers extensions of the designs for extraction and purification of other critical metals including nickel, cobalt, rare earth elements, and platinum group metals. It also designs, develops and commercializes MIP solutions across a spectrum of industries.


GREY:SIXWF - Post by User

Comment by throwaway11on Jan 27, 2023 7:36pm
144 Views
Post# 35251327

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The News didn’t help. What a disappointment.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The News didn’t help. What a disappointment.Agreed nothing is soon enough to offset more dilution. I did some research a while ago and didn't get around to posting it, but it turns out Canada no longer has an expedited approval program for COVID-19 tests. This is frankly a huge blow to both SIXW and whoever their licensing partners are.

Won't pretend I understand what is going on with Magnus. Iscfa seems to have a better idea than I do based on what he read in the MD&A. Speaking of which, I see 2022's third quarter was just released. I absolutely don't want to read it and hat is off to anyone who can stomache what ever it is in right now.

Happy weekend.

BadenBaden wrote:
Sorry if I confused you.

My point was exactly your point that the cannabis sector has been a major disappointment (although I made a good amount of money out of it) as it is overhyped, manipulated by wallstreet & other exchanges, still an unknown market, last but not the least it's still big in the underground market.    Yet SIXW chose to use portion of the debenture towards that side (AESI being cannabis/botanicals). 

I hope this risk is worth it because I don't think they have anything else in the pipeline anyways except for Magnus. Rest are all MOUs, LOIs or product testing (been like this for YEARS)





<< Previous
Bullboard Posts
Next >>